Lipoprotein‐associated phospholipase A2: The story continues

F Huang, K Wang, J Shen - Medicinal research reviews, 2020 - Wiley Online Library
Inflammation is thought to play an important role in the pathogenesis of vascular diseases.
Lipoprotein‐associated phospholipase A2 (Lp‐PLA2) mediates vascular inflammation …

The multifunctional contribution of FGF signaling to cardiac development, homeostasis, disease and repair

F Khosravi, N Ahmadvand, S Bellusci… - Frontiers in cell and …, 2021 - frontiersin.org
The current focus on cardiovascular research reflects society's concerns regarding the
alarming incidence of cardiac-related diseases and mortality in the industrialized world and …

FGF23: a review of its role in mineral metabolism and renal and cardiovascular disease

A Kurpas, K Supeł, K Idzikowska… - Disease Markers, 2021 - Wiley Online Library
FGF23 is a hormone secreted mainly by osteocytes and osteoblasts in bone. Its pivotal role
concerns the maintenance of mineral ion homeostasis. It has been confirmed that phosphate …

Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation

T Pol, Z Hijazi, J Lindbäck, J Oldgren… - Cardiovascular …, 2022 - academic.oup.com
Aims Atrial fibrillation (AF) is associated with higher mortality. Biomarkers may improve the
understanding of key pathophysiologic processes in AF that lead to death. Using a new …

High-dose intravenous iron with either ferric carboxymaltose or ferric derisomaltose: a benefit-risk assessment

JMM Boots, RAM Quax - Drug safety, 2022 - Springer
The intravenous iron formulations ferric carboxymaltose (FCM) and ferric derisomaltose
(FDI) offer the possibility of administering a large amount of iron in one infusion. This results …

Cystatin C for risk stratification in patients after an acute coronary syndrome

S Correa, DA Morrow, E Braunwald… - Journal of the …, 2018 - ahajournals.org
Background Cystatin C (Cys‐C) is a marker of renal function that has shown prognostic
value for cardiovascular risk stratification across different patient populations. The …

Clinical potential of targeting fibroblast growth Factor‐23 and αKlotho in the treatment of uremic cardiomyopathy

JP Law, AM Price, L Pickup… - Journal of the …, 2020 - ahajournals.org
Chronic kidney disease is highly prevalent, affecting 10% to 15% of the adult population
worldwide and is associated with increased cardiovascular morbidity and mortality. As …

Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis

J Li, C Xu, Y Liu, Y Li, S Du, R Zhang, Y Sun… - Basic Research in …, 2020 - Springer
Ventricular arrhythmia is the most common cause of sudden cardiac death in patients with
myocardial infarction (MI). Fibroblast growth factor 21 (FGF21) has been shown to play an …

Targeting aging with the healthy skeletal system: The endocrine role of bone

XQ Zheng, JL Lin, J Huang, T Wu, CL Song - Reviews in Endocrine and …, 2023 - Springer
Aging is an inevitable biological process, and longevity may be related to bone health.
Maintaining strong bone health can extend one's lifespan, but the exact mechanism is …

Emerging biomarkers for predicting clinical outcomes in patients with heart disease

K Pál, IB Mănescu, S Lupu, M Dobreanu - Life, 2023 - mdpi.com
Cardiovascular disease is most frequently caused by the development and progression of
atherosclerosis. When coronary arteries are afflicted, and the stenoses caused by …